Medlive Technology will hold its annual general meeting (AGM) on 15 May 2026 in Beijing to secure shareholder approval for several key resolutions.

• Final dividend: The board recommends a final dividend of RMB0.1435 (HK$0.1629) per share for FY 2025. The books close from 21 May to 26 May 2026 with payment slated for on or around 12 Jun 2026.

• Capital mandates:  – Share buy-back mandate of up to 10% of issued shares, equal to 73.996 million shares based on the 0.74 billion shares outstanding on 14 Apr 2026.  – Share-issue mandate of up to 20% of issued shares, permitting the allotment of 147.992 million new shares, extendable by any shares repurchased.

• Board changes: Re-election of Executive Director Tian Lixin, Non-executive Director Kazutaka Kanairo and Independent Non-executive Director Richard Yeh.

• Auditor transition: Ernst & Young will retire at the AGM; Deloitte Touche Tohmatsu is proposed as successor, with an agreed FY 2026 audit fee of RMB1.80 million.

• Governance update: Shareholders will vote on adopting a third amended and restated Memorandum and Articles of Association to reflect HKEX’s paperless listing regime, including provisions for electronic communications, online meeting participation and other housekeeping changes.

Key timeline: The share register closes 12 – 15 May 2026 for AGM eligibility; proxy forms must be lodged at least 48 hours before the meeting.